Mammalian and arthropod cell cultures were used to assess the neutralizing activity of six monoclonal antibodies specific for the G I glycoprotein of La Crosse virus. Four antibodies, two neutralizing and two non-neutralizing, showed no host-dependent differences, giving similar results when post-treatment infectivity was determined using either Aedes albopietus cells or BHK-21 cells. For two other antibodies, however, dissimilar activities were observed between the vertebrate and invertebrate cell lines. One of these antibodies was positive when BHK-21 cells were employed as the posttreatment host and negative when mosquito cells were used ; the other antibody was the converse. The epitope for this last antibody was present on all California serogroup viruses examined, which suggests that it may have a special significance in the natural life-cycle of the virus.
Two Monoclonal Antibodies against La Crosse Virus Show Host-dependent
Neutralizing Activity 
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SUMMARY Mammalian and arthropod cell cultures were used to assess the neutralizing activity of six monoclonal antibodies specific for the G I glycoprotein of La Crosse virus. Four antibodies, two neutralizing and two non-neutralizing, showed no host-dependent differences, giving similar results when post-treatment infectivity was determined using either Aedes albopietus cells or BHK-21 cells. For two other antibodies, however, dissimilar activities were observed between the vertebrate and invertebrate cell lines. One of these antibodies was positive when BHK-21 cells were employed as the posttreatment host and negative when mosquito cells were used ; the other antibody was the converse. The epitope for this last antibody was present on all California serogroup viruses examined, which suggests that it may have a special significance in the natural life-cycle of the virus.
La Crosse virus (LAC) is an arbovirus belonging to the California serogroup of the family Bunyaviridae (Porterfield et al., 1975/76) . Although it is able to infect humans with sometimes serious consequences (Thompson et al., 1965) , the natural cycle of LAC primarily involves complex interactions between mosquitoes themselves and between mosquitoes and various small mammals (for review, see Grimstad, 1983) .
At the molecular level the virions contain a tripartite genome of negative-stranded RNA and four polypeptides : the large (G 1 ) and small (G2) envelope glycoproteins, a nucleocapsid protein (N), and a minor, large protein (L) also associated with the nucleocapsid (Obijeski et al., 1976a, b; Gentsch & Bishop, 1978 , 1979 .
Studies by Kingsford & Hill (1981) have shown that only antiserum specific for the G 1 protein has neutralizing activity. These data have been supported by more recent results with monoclonal antibodies (Gonzalez-Scarano et al., 1982; Grady et al., 1983a; Kingsford et al., 1983) .
In a previous report from our laboratory a set of monoclonal antibodies specific for the G1 protein of LAC were described (Grady et al., 1983a) . Some of these antibodies were positive in both neutralization and haemagglutination-inhibition (HI) tests, one had only HI activity, and several others lacked both activities and could not be associated with any biological property of the virus. Additional experiments employing competitive binding assays indicated that the epitopes for at least two of the non-neutralizing antibodies might reside in separate antigenic sites on the GI protein (Grady et al., 1983b) .
In all of the studies referred to above, from this laboratory as well as others, rnonoclonal antibodies were considered to be neutralizing or non-neutralizing depending on whether or not they interfered with the ability of LAC to infect mammalian cells. However, in view of the importance of insects in the natural life-cycle of the virus, it seemed reasonable to ask if there are differences between arthropod and mammalian cells with respect to the neutralizing ability of the various antibodies. In particular, is there any evidence for a biological role in arthropod cells 0000-6741 © 1985 SGM for any of the epitopes on the G 1 protein where the corresponding antibodies showed no activity when tested in mammalian cells?
The prototype strain of LAC (Thompson et al., 1965) and the Aedes albopictus line of mosquito cells (ATCC no. CCL 126) were used in all of the experiments. The passage history of the virus in our laboratory has been given elsewhere (Grady et al., 1983 a) . Virus stocks were prepared and titrated in BHK-21 cells. Mosquito cell cultures were grown in MM medium (Mitsuhashi & Maramorosch, 1964) in plastic flasks at 28 °C. Immediately before use, the cells were harvested by vigorously rinsing the growth surface, counted, collected by centrifugation and resuspended in fresh growth medium at 4 × 106 cells/ml.
All of the monoclonal antibodies employed were of the IgG2a subclass and were purified from ascitic fluid by passage over a column of Protein A-Sepharose as previously described (Grady et al., 1983a) .
As is the case for many other arboviruses, LAC does not produce a cytopathic effect when grown in mosquito cells (Lyons & Heyduk, 1973) and thus direct plaquing on these cells was not possible. Instead, the effect of the monoclonal antibodies on virus infectivity was determined by an infective centre assay similar to that reported by Davey et al. (1973) . The procedure consisted of diluting stock virus 1:5 with MM medium and splitting the dilution into three 0.5 ml portions. The first portion received 40 ~tg of monoclonal antibody, the second 15 ~tg and the third served as control. After incubation for 1 h at 37 °C, 0-5 ml MM medium containing 2 x 106 A. albopictus cells was added to each portion and incubation at 37 °C continued for an additional 90 min. The cells were then collected by centrifugation and washed once with l0 ml MM medium. Each portion was resuspended in 0.5 ml growth medium and either a mixture of neutralizing monoclonal antibodies or conventional LAC antiserum was added to neutralize any remaining unadsorbed virus (both treatments gave similar results). After a 1 h incubation the cells were collected by centrifugation, washed three times with 10 ml MM medium and resuspended in 0.6 ml growth medium. Serial tenfold dilutions of each portion were then plated (0.1 ml) in duplicate on BHK-21 cells, overlaid with agar, incubated for 72 h at 37 °C, stained with neutral red and the plaques counted. As an additional precaution, the remainder of the undiluted cell suspensions were centrifuged and the supernatants tested for free virus in the same manner. This latter control never yielded more than one or two plaques. The experiments shown in Table 2 were identical to the above except that BHK cells were substituted for the mosquito cells.
The results of the infective centre experiments are presented in Table 1 . The first three antibodies for which data are given (5D4, 7B11, 3G8) had previously been shown to neutralize LAC when post-treatment infectivity was measured with BHK-21 cells (Grady et al., 1983 a) and two of these (5D4, 7B11) behaved similarly in experiments with A. albopictus cells. The third antibody (3G8), however, was non-neutralizing when its effect was evaluated with mosquito cells. Nevertheless, earlier results from competition experiments indicated that the epitopes for all three of these antibodies are located in the same general region of the viral G 1 protein (Grady et al., 1983b) . This suggests that individual epitopes within a single antigenic domain can vary depending on the host cell with respect to their role in virus neutralization. However, it should also be noted that the epitope for antibody 3G8 has so far been found only on some isolates of LAC and not on any of the other viruses of the California encephalitis (CE) complex.
The fourth antibody studied, 2B9, also showed host cell-related differences with regard to virus neutralization. In this instance the antibody had little or no activity when BHK-21 cells were used (Table 2 ; Grady et al., 1983a ) but effectively neutralized virus in experiments with mosquito cells (Table 1) . To the best of our knowledge, these data are the first to implicate a specific site on the LAC virion with preferential interaction with insect cells. This finding is especially interesting because the epitope for 2B9 is widely conserved among the California serogroup viruses. It has been detected by HI and ELISA on the reference strains of all North American members of the CE complex (Grady et al., 1983 a) and more recently by ELISA (data not shown) on reference strains of the other viruses of this group (Inkoo, Tahyna, Lumbo, Melao, Serra do Navio). In addition, in competition experiments evidence was obtained that the epitope for antibody 2B9 resides in a region of the G1 glycoprotein distinct from those of the other antibodies studied (G rady et al., 1983 b) . When all of these data are considered together, it does not seem unreasonable to hypothesize that the 2B9 binding site on the G1 protein may be an important determinant in the interaction of CE complex viruses with their arthropod vectors. The last two monoclonal antibodies examined, 1AT and 5D2, had no neutralizing activity against LAC, regardless of which cell line was employed. As a result, it still has not been possible to correlate either antibody with any biological property of the virus.
In conclusion, our experiments have identified two monoclonal antibodies against the G1 glycoprotein of LAC whose neutralizing activity depended on the cell line with which it was assessed: 3G8, which was positive solely with BHK-21 cells, and 2B9, which was only active with the mosquito cells. Because of this differential activity, these antibodies provide a starting point from which to begin the molecular characterization of those regions of the G1 protein concerned with tissue tropisms.
